| Tumor mutational load predicts survival after immunotherapy across multiple cancer types RM Samstein, CH Lee, AN Shoushtari, MD Hellmann, R Shen, ... Nature genetics 51 (2), 202-206, 2019 | 3096 | 2019 |
| Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ... Nature medicine 23 (6), 703-713, 2017 | 2936 | 2017 |
| Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies EJ Jordan, HR Kim, ME Arcila, D Barron, D Chakravarty, JJ Gao, ... Cancer discovery 7 (6), 596-609, 2017 | 574 | 2017 |
| Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making W Abida, J Armenia, A Gopalan, R Brennan, M Walsh, D Barron, D Danila, ... JCO precision oncology 1, 1-16, 2017 | 504 | 2017 |
| The reactive stroma microenvironment and prostate cancer progression DA Barron, DR Rowley Endocrine-related cancer 19 (6), R187-R204, 2012 | 355 | 2012 |
| RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation W Kim, DA Barron, R San Martin, KS Chan, LL Tran, F Yang, SJ Ressler, ... Proceedings of the National Academy of Sciences 111 (46), 16389-16394, 2014 | 156 | 2014 |
| Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy EJ Pietzak, EC Zabor, A Bagrodia, J Armenia, W Hu, A Zehir, S Funt, ... European urology 75 (2), 231-239, 2019 | 125 | 2019 |
| Mechanical stretch activates nuclear factor‐kappaB, activator protein‐1, and mitogen‐activated protein kinases in lung parenchyma: implications in asthma A Kumar, S Lnu, R Malya, D Barron, J Moore, DB Corry, AM Boriek The FASEB journal 17 (13), 1800-1811, 2003 | 120 | 2003 |
| Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies. Cancer Discov. 2017; 7: 596–609 … EJ Jordan, HR Kim, ME Arcila, D Barron, D Chakravarty, J Gao, ... DOI: https://doi. org/10.1158/2159-8290. CD-16-1337. PMID: https://www. ncbi …, 0 | 102 | |
| Recruitment of CD34+ fibroblasts in tumor-associated reactive stroma: The reactive microvasculature hypothesis R San Martin, DA Barron, JA Tuxhorn, SJ Ressler, SW Hayward, X Shen, ... The American journal of pathology 184 (6), 1860-1870, 2014 | 54 | 2014 |
| TGF-β1 induces an age-dependent inflammation of nerve ganglia and fibroplasia in the prostate gland stroma of a novel transgenic mouse DA Barron, DW Strand, SJ Ressler, TD Dang, SW Hayward, F Yang, ... PLoS One 5 (10), e13751, 2010 | 47 | 2010 |
| Erratum: Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients A Zehir, R Benayed, RH Shah, A Syed, S Middha, HR Kim, P Srinivasan, ... Nature Medicine 23 (8), 1004-1004, 2017 | 43 | 2017 |
| TGF-β induction of FGF-2 expression in stromal cells requires integrated smad3 and MAPK pathways DW Strand, YY Liang, F Yang, DA Barron, SJ Ressler, IG Schauer, ... American journal of clinical and experimental urology 2 (3), 239, 2014 | 33 | 2014 |
| WFDC1 is a key modulator of inflammatory and wound repair responses SJ Ressler, TD Dang, SM Wu, YT Dennis, BE Gilbert, A Vyakarnam, ... The American Journal of Pathology 184 (11), 2951-2964, 2014 | 19 | 2014 |
| PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT) NA Lockney, TJ Yang, D Barron, E Gelb, DY Gelblum, E Yorke, W Shi, ... Clinical and translational radiation oncology 7, 91-93, 2017 | 17 | 2017 |
| Identifying HER2 mutation, amplification, and HER2 protein overexpression as therapeutic targets in lung cancers. BT Li, T Zheng, A Ni, MD Hellmann, E Jordan, D Barron, LM Smyth, ... Journal of Clinical Oncology 34 (15_suppl), e20666-e20666, 2016 | 10 | 2016 |
| Next-generation sequencing (NGS) of tissue and cell free DNA (cfDNA) to identify somatic and germline alterations in advanced prostate cancer. ML Cheng, W Abida, DE Rathkopf, ME Arcila, D Barron, KA Autio, A Zehir, ... Journal of Clinical Oncology 35 (15_suppl), 5010-5010, 2017 | 2 | 2017 |
| Human prostate mesenchymal stem cells in prostate cancer: Mechanisms of TGF-β1 promoted myofibroblast/CAF differentiation W Kim, D Barron, S Ressler, D Rowley Cancer Research 72 (8_Supplement), 4265-4265, 2012 | 2 | 2012 |
| The role of mechanical stress in skeletal myocytes: MAPK signal transduction pathways DA Barron, A Kumar, AM Boriek Reviews in Undergraduate Research 1, 8-20, 2002 | 2 | 2002 |
| The Role of Radiation Therapy in Epstein-Barr Virus–Related Lymphoproliferative Disorder DA Barron, SE Prockop, SL Wolden International Journal of Radiation Oncology, Biology, Physics 90 (1), S732-S733, 2014 | 1 | 2014 |
